CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $1.77M invested in Can-Fite BioPharma in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$35K
2
+$1K

Top Sellers

1
-$705K
2
-$74.4K
3
-$41.9K
4
Creative Planning
Creative Planning
Kansas
-$14K
5
VKH
Virtu KCG Holdings
New York
-$6.35K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.54M
2
$106K
3
$44K
4
$35K
5
$30K
6
$6K
7
$3K
8
$1K
9
–
10
–
11
–